Primary Systemic Therapy of Breast Cancer-Reference-Cited by-同舟云学术

Primary Systemic Therapy of Breast Cancer

Published:2006-06-01 Issue:6 Volume:11 Page:574-589
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Sachelarie Irina¹,Grossbard Michael L.¹,Chadha Manjeet¹,Feldman Sheldon¹,Ghesani Munir¹,Blum Ronald H.¹

Affiliation:

1. St. Luke's-Roosevelt Medical Center, Beth Israel Medical Center, Continuum Cancer Center of New York, New York, New York, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: Describe the rationale for using primary systemic therapy (PST) in the treatment of nonmetastatic breast cancer.Discuss the pathologic complete response (pCR) rate as a surrogate marker of PST benefit.Select the most appropriate regimen for a patient with breast cancer considered for PST.Explain the role of sentinel node biopsy and delivery of radiation therapy after PST in breast cancer patients. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.11-6-574

Reference112 articles.

1. Presence of a growth-stimulating factor in serum following primary tumor removal in mice;Fisher;Cancer Res,1989

2. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression;Holmgren;Nat Med,1995

3. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18;Fisher;J Clin Oncol,1997

4. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

5. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of radiomics-based machine-learning classifiers for the pretreatment prediction of pathologic complete response to neoadjuvant therapy in breast cancer;PeerJ;2024-07-15

2. The Current Role of Neoadjuvant Chemotherapy in the Management of HER2-Positive, Triple-Negative, and Micropapillary Breast Cancer: A Narrative Review;Cureus;2023-11-30

3. Clinical evaluation of neoadjuvant tyrosine kinase inhibitor administration for mast cell tumours in eight dogs;Veterinary Record Case Reports;2023-06

4. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer;Journal of Clinical Oncology;2023-04-01

5. Recent advances in atezolizumab-based programmed death-ligand 1 (PD-L1) blockade therapy for breast cancer;International Immunopharmacology;2022-12